Learn More
CXCR5 (extracellular) Polyclonal Antibody, Invitrogen™
Rabbit Polyclonal Antibody
Brand: Invitrogen PA5111766
Additional Details : Weight : 0.01000kg
Description
Reconstitute antibody with 50 μL of double distilled water (DDW). The reconstituted solution can be stored at 4 degrees C for up to 1 week. For longer periods, small aliquots should be stored at -20 degrees C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min). Peptide sequence is: RLDNYNDTSL VENHLC Homology: Human only.
CXCR5 (C-X-Chemokine Receptor Type 5, CD185) also known as Burkitt lymphoma receptor 1 (BLR1) belongs to the CXC chemokine receptor family. CXCR5 is a G protein-coupled seven transmembrane receptor for chemokine BLC. CXCR5 gene is specifically expressed in Burkitt′s lymphoma and lymphatic tissues, such as follicles in lymph nodes, as well as in spleen. Studies of CXCR5 suggest that it plays an essential role in B cell migration. CXCR5 expression has been reported in human blood and salivary gland and in animal lymphatic organs, blood, bone marrow, brain, liver, lymph node, skin, spleen, stomach, and tonsil. ESTs (expressed sequence tags) have been isolated from human brain, germ cell, lung, lymph, and pancreas. G-protein Coupled Receptors (GPCRs) comprise one of the largest families of signaling molecules with more than a thousand members currently predicted to exist. All GPCRs share a structural motif consisting of seven membrane-spanning helices, and exist in both active and inactive forms. An array of activating ligands participate in the conformation of GPCRs which leads to signaling via G-proteins and downstream effectors. Research studies have also shown the vast series of reactions which participate in the negative regulation of GPCRs. This 'turn-off' activity in GPCRs have tremendous implications for the physiological action of the cell, and continues to drive pharmacological research for new drug candidates. Two blockbuster drugs which have been developed as GPCR-targeted pharmaceuticals are Zyprexa (Eli Lilly) and Claritin (Schering-Plough) which are used in mental health and allergy applications, respectively.Specifications
CXCR5 (extracellular) | |
Polyclonal | |
Unconjugated | |
CXCR5 | |
BLR1; Blr-1; Burkitt lymphoma receptor 1; Burkitt lymphoma receptor 1 homolog; C Cmotif chemokine; C X C motif chemokine; CC motif chemokine; CCmotif chemokine; CD185; CD185 antigen; CXC; C-X-C chemokine receptor type 5; CXC motif chemokine; Cxcr5; CXC-R5; CXCR-5; EGK_06966; Fusin; Gpcr6; GPR9; HUMSTR; LESTR; MDR15; MDR-15; Monocyte-derived receptor 15; Neurolymphatic receptor; NLR | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
643 | |
-20°C | |
Lyophilized |
Flow Cytometry, Immunocytochemistry, Immunofluorescence, Immunomicroscopy, Western Blot | |
0.85 mg/mL | |
PBS with 1% BSA and 0.05% sodium azide; pH 7.4 | |
P32302 | |
CXCR5 | |
Peptide corresponding to amino acid residues 23-38 of human CXCR5 (Extracellular, N-terminus) | |
50 μL | |
Primary | |
Human | |
Antibody | |
IgG |